Impact of sodium bicarbonate therapy on hemodynamic parameters in infants: a meta-analysis

Rohit S Loomba1, Mubeena Abdulkarim1, Ronald A Bronicki2

  • 1Division of Cardiology, Chicago Medical School, Advocate Children's Hospital, Chicago, IL, USA.

Insights

Sodium bicarbonate improved base deficit and carbon dioxide levels in critically ill infants. However, these changes were not clinically significant, with no impact on other vital signs or oxygenation.

Area of Science:

  • Pediatric Critical Care Medicine
  • Neonatology
  • Pediatric Emergency Medicine

Background:

  • Metabolic acidosis is common in critically ill children.
  • Sodium bicarbonate is frequently used to treat metabolic acidosis.
  • Its effects on hemodynamics, gas exchange, and oximetry in this population require clarification.

Purpose of the Study:

  • To systematically review and meta-analyze the effects of sodium bicarbonate on hemodynamics, gas exchange, and oximetry in critically ill children with metabolic acidosis.

Main Methods:

  • Systematic review of published studies involving children treated with sodium bicarbonate for metabolic acidosis.
  • Meta-analysis to assess the impact on base deficit, heart rate, mean arterial pressure, carbon dioxide levels, pH, and pulse oximetry.

Main Results:

  • Six studies with 341 critically ill infants (mean age 1.1 months) were included.
  • Sodium bicarbonate administration (mean dose 1.7 meq/kg) significantly improved base deficit (decrease of 2.80) and decreased partial pressure of carbon dioxide (-1.65 mmHg).
  • No significant changes were observed in heart rate, mean arterial pressure, pH, partial pressure of oxygen, or pulse oximetry saturation.

Conclusions:

  • Sodium bicarbonate shows statistically significant but not clinically significant improvements in base deficit and carbon dioxide levels in critically ill infants.
  • No discernible impact on pH, oxygenation, or hemodynamics was noted within 60 minutes of administration.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
149
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
115
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
178
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
906
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
155
Bicarbonate-Carbonic Acid Buffer01:22

Bicarbonate-Carbonic Acid Buffer

The carbonic acid-bicarbonate buffer system is critical for maintaining the body's pH balance. It operates on the equilibrium:
4.8K